CTAS
Price
$224.04
Change
+$3.89 (+1.77%)
Updated
Oct 22 closing price
Capitalization
89.51B
56 days until earnings call
Intraday BUY SELL Signals
EXPO
Price
$77.11
Change
+$3.96 (+5.41%)
Updated
Oct 22 closing price
Capitalization
3.67B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTAS vs EXPO

CTAS vs EXPO Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Oct 20, 2026

Which Stock Would AI Choose? Cintas Corporation (CTAS) vs. Exponent, Inc. (EXPO) Stock Comparison

Key Takeaways

  • CTAS is a large-cap uniform rental and facility-services leader with durable, subscription-style revenue; EXPO is a smaller, project-based engineering and scientific consulting firm.
  • Cintas reported record margins and raised full-year guidance, while its pending UniFirst acquisition remains a key catalyst awaiting regulatory approval.
  • Exponent has delivered accelerating revenue growth tied to AI safety, failure analysis, and utility risk management, but its business is more cyclical and less recurring than Cintas's.
  • The two companies differ sharply in scale, sector exposure, and valuation, offering contrasting risk-and-reward profiles for investors.
  • Relative performance and market positioning diverge: CTAS reflects steady compounding, while EXPO reflects faster growth with higher execution sensitivity.

Introduction

Investors weighing quality, growth, and valuation often compare companies with very different business models to clarify where their capital might best be allocated. CTAS (Cintas Corporation) is an industrials stalwart providing uniform rental, facility services, and first aid and safety solutions. EXPO (Exponent, Inc.) is a specialized science and engineering consulting firm that helps clients solve high-stakes technical problems. This stock comparison is relevant to traders and long-term investors who want to understand how a steady, recurring-revenue compounder contrasts with a faster-growing, project-oriented consultancy in today's market environment.

CTAS Overview and Recent Performance

Cintas is a Fortune 500 company headquartered in Cincinnati and a component of both the S&P 500 and Nasdaq-100. Its core business rents and services employee uniforms, mats, mops, and restroom supplies, while its First Aid and Safety Services and Fire Protection segments broaden its offering. Because revenue grows with its customers' headcount and is largely contractual, the model is widely viewed as recurring and resilient.

In recent market activity, CTAS has traded near its 52-week highs, supported by strong fundamentals. The company reported organic revenue growth near 9%, a record gross margin, and meaningful operating-margin expansion, and it raised full-year revenue and earnings guidance. Sentiment has also been shaped by the pending acquisition of UniFirst, which awaits regulatory clearance from the Federal Trade Commission (FTC). The deal could materially expand Cintas's North American market share, though the extended regulatory review adds timing uncertainty. A long history of dividend increases reinforces the stock's appeal to income- and quality-focused investors.

EXPO Overview and Recent Performance

Exponent is a science and engineering consulting firm that combines more than 90 technical disciplines to address failure analysis, product safety, and risk-management challenges across industries including consumer electronics, energy, life sciences, and construction. Unlike Cintas's recurring rental model, Exponent's revenue is project-based and driven by billable hours, utilization rates, and consultant headcount.

In recent quarters, EXPO has shown accelerating momentum. Total revenue rose 14% year over year in its fiscal first quarter and roughly 21% in its second quarter, with earnings per share (EPS) consistently exceeding analyst expectations. Growth has been led by user research for consumer-electronics clients integrating artificial intelligence (AI), utility asset-risk work tied to extreme weather, and reactive engagements in energy and medical devices. The company has also expanded share repurchases and transitioned its leadership team. At the same time, analysts note a two-sided dynamic: AI creates demand for Exponent's failure-analysis expertise, yet automation could pressure billable hours across the consulting industry.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page curates a selection of AI-powered trading bots tailored to current market conditions. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of tickers, spanning a wide range of strategies, timeframes, performance statistics, and risk profiles. Because not every bot suits every market environment, only the most suitable and best-performing candidates earn a place in the Trending AI Robots section. Each bot operates with its own trading style, target universe, and historical track record, allowing users to evaluate performance metrics before making decisions. Explore the Trending AI Robots page to review the available bots and their statistics.

Head-to-Head Comparison

The clearest contrast between the two companies is business-model predictability. Cintas generates recurring revenue through long-standing rental and service contracts, which supports steady margins and reliable cash flow. Exponent earns revenue engagement by engagement, making its results more sensitive to client budgets, project timing, and consultant utilization.

Growth drivers also differ. Cintas's expansion is tied to employment trends, cross-selling into adjacent services, and the potential UniFirst merger. Exponent's growth is linked to rising technical complexity, AI integration into physical systems, and regulatory demands for safety and reliability. This gives Exponent a more direct, albeit more volatile, exposure to technology-driven demand.

On scale and valuation, Cintas is a far larger enterprise with a premium price-to-earnings ratio that reflects its quality and stability. Exponent is smaller, with a higher-growth profile but also greater earnings cyclicality. Risk factors diverge accordingly: Cintas faces regulatory and integration risk around its acquisition, while Exponent faces utilization and automation-related headwinds in consulting.

Tickeron AI Verdict

Based on observable trend consistency, stability, and relative positioning, Tickeron's AI would likely favor CTAS for its steadier trend profile, recurring revenue, and consistent margin execution, while recognizing EXPO as the stronger near-term growth catalyst. The probabilistic assessment leans toward Cintas for investors prioritizing durability and lower volatility, whereas Exponent may appeal to those seeking faster top-line acceleration and greater sensitivity to AI-driven demand. Neither conclusion is definitive, as outcomes will depend on regulatory decisions, execution, and shifting market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
CTAS vs. EXPO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTAS is a Buy and EXPO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CTAS with price predictions
Oct 22, 2026

CTAS in upward trend: price rose above 50-day moving average on October 08, 2026

CTAS moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on CTAS as a result. In 54 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

The Moving Average Convergence Divergence (MACD) for CTAS just turned positive on October 08, 2026. Looking at past instances where CTAS's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.

The 10-day moving average for CTAS crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTAS advanced for three days, in 194 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

The Aroon Indicator entered an Uptrend today. In 166 of 314 cases where CTAS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 38%.

CTAS broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 18 (best 1 - 100 worst), indicating outstanding price growth. CTAS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.414) is normal, around the industry mean (5.965). P/E Ratio (45.078) is within average values for comparable stocks, (32.441). Projected Growth (PEG Ratio) (3.144) is also within normal values, averaging (1.946). Dividend Yield (0.009) settles around the average of (0.025) among similar stocks. P/S Ratio (7.194) is also within normal values, averaging (9.694).

A.I.Advisor
a Summary for EXPO with price predictions
Oct 22, 2026

EXPO in upward trend: 10-day moving average moved above 50-day moving average on October 12, 2026

The 10-day moving average for EXPO crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on EXPO as a result. In 54 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for EXPO just turned positive on October 02, 2026. Looking at past instances where EXPO's MACD turned positive, the stock continued to rise in 24 of 45 cases over the following month. The odds of a continued upward trend are 53%.

EXPO moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXPO advanced for three days, in 163 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

EXPO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EXPO entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. EXPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.703) is normal, around the industry mean (15.458). P/E Ratio (34.424) is within average values for comparable stocks, (169.275). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (3.522). Dividend Yield (0.016) settles around the average of (0.192) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (2.905).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

FUNDAMENTALS RATINGS
CTAS vs EXPO: Fundamental Ratings
CTAS
EXPO
OUTLOOK RATING
1..100
4544
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
17100
SMR RATING
1..100
2631
PRICE GROWTH RATING
1..100
1841
P/E GROWTH RATING
1..100
3442
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EXPO's Valuation (87) in the Engineering And Construction industry is in the same range as CTAS (93) in the Other Consumer Services industry. This means that EXPO’s stock grew similarly to CTAS’s over the last 12 months.

CTAS's Profit vs Risk Rating (17) in the Other Consumer Services industry is significantly better than the same rating for EXPO (100) in the Engineering And Construction industry. This means that CTAS’s stock grew significantly faster than EXPO’s over the last 12 months.

CTAS's SMR Rating (26) in the Other Consumer Services industry is in the same range as EXPO (31) in the Engineering And Construction industry. This means that CTAS’s stock grew similarly to EXPO’s over the last 12 months.

CTAS's Price Growth Rating (18) in the Other Consumer Services industry is in the same range as EXPO (41) in the Engineering And Construction industry. This means that CTAS’s stock grew similarly to EXPO’s over the last 12 months.

CTAS's P/E Growth Rating (34) in the Other Consumer Services industry is in the same range as EXPO (42) in the Engineering And Construction industry. This means that CTAS’s stock grew similarly to EXPO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTASEXPO
RSI
ODDS (%)
Bearish Trend 1 day ago
31%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
56%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
58%
Declines
ODDS (%)
Bearish Trend 23 days ago
38%
Bearish Trend 28 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
61%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CTAS: $220.15 vs. EXPO: $73.15)
Brand notoriety: CTAS and EXPO are both not notable
CTAS represents the Office Equipment/Supplies, while EXPO is part of the Engineering & Construction industry
Current volume relative to the 65-day Moving Average: CTAS: 151% vs. EXPO: 56%
Market capitalization -- CTAS: $89.51B vs. EXPO: $3.67B
CTAS [@Office Equipment/Supplies] is valued at $89.51B. EXPO’s [@Engineering & Construction] market capitalization is $3.67B. The market cap for tickers in the [@Office Equipment/Supplies] industry ranges from $47.27K to $89.51B. The market cap for tickers in the [@Engineering & Construction] industry ranges from $69 to $2.15T. The average market capitalization across the [@Office Equipment/Supplies] industry is $7.74B. The average market capitalization across the [@Engineering & Construction] industry is $7.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTAS’s FA Score shows that 3 FA rating(s) are green while EXPO’s FA Score has 1 green FA rating(s).

  • CTAS’s FA Score: 3 green, 2 red.
  • EXPO’s FA Score: 1 green, 4 red.
According to our system of comparison, CTAS is a better buy in the long-term than EXPO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTAS’s TA Score shows that 5 TA indicator(s) are bullish while EXPO’s TA Score has 7 bullish TA indicator(s).

  • CTAS’s TA Score: 5 bullish, 5 bearish.
  • EXPO’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, EXPO is a better buy in the short-term than CTAS.

Price Growth

CTAS (@Office Equipment/Supplies) experienced а +5.52% price change this week, while EXPO (@Engineering & Construction) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Office Equipment/Supplies industry was -1.26%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -2.49%.

The average weekly price growth across all stocks in the @Engineering & Construction industry was -6.51%. For the same industry, the average monthly price growth was -15.54%, and the average quarterly price growth was -29.20%.

Reported Earning Dates

CTAS is expected to report earnings on Dec 17, 2026.

EXPO is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Office Equipment/Supplies (-1.26% weekly)

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

@Engineering & Construction (-6.51% weekly)

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

View a ticker or compare two or three
CTAS
Daily Signal:
Gain/Loss:
EXPO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CTAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTAS has been loosely correlated with EXPO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CTAS jumps, then EXPO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTAS
1D Price
Change %
CTAS100%
+1.77%
EXPO - CTAS
62%
Loosely correlated
+5.41%
UNF - CTAS
53%
Loosely correlated
+1.82%
VRSK - CTAS
51%
Loosely correlated
+5.71%
ARLO - CTAS
47%
Loosely correlated
+3.70%
EFX - CTAS
46%
Loosely correlated
+6.59%
More

EXPO and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXPO has been loosely correlated with CTAS. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EXPO jumps, then CTAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXPO
1D Price
Change %
EXPO100%
+5.41%
CTAS - EXPO
62%
Loosely correlated
+1.77%
ALLE - EXPO
61%
Loosely correlated
+11.02%
CBZ - EXPO
59%
Loosely correlated
+0.07%
DLB - EXPO
58%
Loosely correlated
+1.22%
TRI - EXPO
55%
Loosely correlated
+6.94%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTSH73.724.17
+6.00%
Cognizant Technology Solutions Corp
ICUI168.337.49
+4.66%
ICU Medical
ABX8.510.01
+0.12%
Abacus Global Management Inc
EQS0.81-0.04
-4.91%
Equus Total Return
FUFU1.00-0.06
-5.91%
BitFuFu